AVITA Medical (RCEL) Non-Current Debt (2023 - 2025)

AVITA Medical (RCEL) has 3 years of Non-Current Debt data on file, last reported at $42.2 million in Q2 2025.

• For the quarter ending Q2 2025, Non-Current Debt rose 2.99% year-over-year to $42.2 million; the trailing twelve-month figure through Jun 2025 stood at $42.2 million (up 2.99% YoY), and the FY2024 full-year result was $42.2 million, up 6.11% from the prior year.
• Non-Current Debt for Q2 2025 stood at $42.2 million, up from $41.5 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $42.5 million in Q3 2024 and bottomed at $39.8 million in Q4 2023.
• The 3-year median for Non-Current Debt is $41.5 million (2025), against an average of $41.5 million.
• The widest annual swing landed in 2024, when Non-Current Debt gained 6.11%; it then gained 0.39% in 2025.
• A 3-year view of Non-Current Debt shows it stood at $39.8 million in 2023, then climbed by 6.11% to $42.2 million in 2024, then decreased by 0.07% to $42.2 million in 2025.
• The last three Non-Current Debt figures came in at $42.2 million (Q2 2025), $41.5 million (Q1 2025), and $42.2 million (Q4 2024), per Business Quant data.

Peer Comparison